Our mission is to provide education and advocacy for Connecticut’s bioscience and life science communities at the policy level and ensure synergy of action and alignment of state and federal initiatives that have a significant impact on our members.
The Government Affairs Committee is comprised of BioCT board members, industry executives and business advisors including the government relations firm of Rome, Smith & Lutz, which has deep expertise in matters impacting our industry.
Dawn Hocevar
President & CEO,
BioCT
Todd Arnold, Ph.D.
Chief Laboratory Operations Officer,
Sema4
BioCT Director
Joni Arvai
Senior Manager, State Government Affairs,
Bristol-Myers Squibb
Kathy Andrews Bilotas
Director of State Government Affairs,
Eli Lilly
Bill Claffey, J.D.
Partner, Tax Services,
Fiondella, Milone & LaSaracina
Jennifer Deperry
Alliance Development Manager,
Pfizer
Jennifer Herz
State Government Affairs, Regional Director,
Boeringer Ingelheim
Ken Hiscoe
Director, US Government Relations/Corporate Affairs,
Pfizer
Richard Jacob
Associate Vice President for Federal Relations,
Yale University
BioCT Director
Delman Lebel
Director, State Government Affairs and Public Policy,
Regeneron Pharmaceuticals
Katherine Lutz
Partner,
Rome, Smith & Lutz
Joseph Oros
Regional Director, State Government Affairs,
AbbVie
Jack Quinn
Head of State Government Affairs,
Alexion
Lonnie Reed
Former State Representative
Lisa Roy
Director of Government & Community Relations,
Jackson Laboratory
Dmitri Siegel
Director, Alliance Development
Bristol-Myers Squibb
Kelly Sinko Steuber
Director, Governmental Relations for Health Affairs,
University of Connecticut
Christopher Smith
Vice President,
Rome Smith & Lutz
Karla White
State Government Affairs Manager, East Coast,
CSL Behring
Dawn Hocevar
President & CEO
BioCT